熱門資訊> 正文

Vor Bio宣布7500万美元私募

2026-03-27 20:20

Vor Biopharma, Inc.(VOR) 0
高宏集團(COWN) 0

Vor Bio (VOR) said on Friday it had entered a securities purchase agreement to sell 5.34M shares at $14.05 each in a private placement, for gross proceeds of about $75M.
The private placement is expected to close on or about March 30, 2026.
The financing is led by new investor TCGX.
The net proceeds from the offering will be used for advancing telitacicept’s clinical program, including ongoing global Phase 3 trials in myasthenia gravis and primary Sjögren's disease, along with business development and general corporate purposes.
Shares +4.87%.

More on Vor Biopharma

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Seeking Alpha’s Quant Rating on Vor Biopharma
Historical earnings data for Vor Biopharma
Financial information for Vor Biopharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。